touyun biotech (01332) has expanded the new application range and space for the production of chlorella, and has started entering the artificial fish, shrimp, and plant milk markets.

touyun biotech (01332) announced that on November 20, 2024, its wholly-owned subsidiary shanxi touyun biotech...

According to the announcement by touyun biotech (01332) on November 20, 2024, its wholly-owned subsidiary shanxi touyun biotech technology co., ltd. received Notice No. [2024] 0009 from the National Health Commission, which stated that the administrative license application for "Rhine Chlorella (white algae)" (later renamed as "Rhine Chlorella") submitted by shanxi touyun biotech technology co., ltd. is essentially equivalent to the Rhine Chlorella mentioned in the National Health Commission's 2022 Announcement No. 2.

Based on this, the group's production of Rhine Chlorella has expanded into new application scopes and spaces, and has started to enter the market for artificial fish, shrimp, and plant-based milk.

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

透云生物(01332)生产的莱茵衣藻扩展了新的应用范围和空间 开始进入人造鱼、虾以及植物奶市场

touyun biotech (01332) has expanded the new application range and space for the production of chlorella, and has started entering the artificial fish, shrimp, and plant milk markets.

Risk Disclaimer

Statement

透云生物(01332)生产的莱茵衣藻扩展了新的应用范围和空间开始进入人造鱼、虾以及植物奶市场